How Is DaVita's Stock Performance Compared to Other Health Care Services Stocks?

DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services for patients suffering from chronic kidney failure. Valued at $12 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and DVA perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical care facilities industry. With over 35% market share in the U.S. dialysis market, DVA is a trusted leader known for quality care and innovation in kidney care. Its integrated approach offers services from diagnosis to transplant support, making it a comprehensive healthcare provider. Its focus on personalized care at scale has built strong patient trust and brand equity, solidifying its market dominance of over 25 years.